Full-Time

Clinical Research Associate

Posted on 4/23/2024

Orca Bio

Orca Bio

51-200 employees

Develops high precision allogeneic cell therapy products

Biotechnology

Junior, Mid

Remote in USA

Required Skills
Google Cloud Platform
Requirements
  • BA/BS or equivalent with a minimum of 2 years of relevant clinical trial management experience
  • Therapeutic experience in oncology/hematology and cell and gene therapy preferred
  • Strong working knowledge of FDA and ICH/GCP regulations and guidelines
  • Experience with Trial Master File management according to the DIA reference model
  • Experience operating within various site EMR/EHR systems
  • Experience using eTMF, EDC (IBM Zelta experience ideal), CTMS, and other vendors systems/portals
Responsibilities
  • Conduct interim monitoring visits (IMVs) and ISF review
  • Review electronic medical records (EMR)/patient dataSource documentation verification (SDV) against case report form data
  • Verification and review of adverse events, serious adverse events, concomitant medications and corresponding illnesses
  • Provide support to site staff including research coordinators and physicians
  • Assist in the development of trial materials as needed
  • Contribute to the development of Clinical Operations SOPs, best practices, work instructions, tools and templates

Orca Bio is a pioneering force in the field of allogeneic cell therapy, leveraging single-cell precision and high purity manufacturing techniques to develop cutting-edge therapeutic mixtures of immune and stem cells. Working here offers the chance to be at the forefront of medical innovation aimed at transforming the landscape of cell therapy. Employees benefit from a dynamic environment committed to groundbreaking research and development, providing ample opportunities for professional growth in a rapidly evolving industry.

Company Stage

Series D

Total Funding

$375M

Headquarters

Menlo Park, California

Founded

2016

Growth & Insights
Headcount

6 month growth

3%

1 year growth

25%

2 year growth

39%
INACTIVE